deltatrials
Completed NA INTERVENTIONAL 1-arm NCT03525912

Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions

Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions: a Prospective Study

Sponsor: Universidad de Antioquia

Interventions Ketamine
Updated 6 times since 2018 Last updated: Mar 27, 2019 Started: Jul 1, 2017 Primary completion: Mar 31, 2018 Completion: Nov 14, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Ketamine Adverse Reaction and Pain, Postoperative and is currently completed. Universidad de Antioquia leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshotRecruiting~Apr 2019 – ~Jan 2021 · 21 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  5. Apr 2019 — Jan 2021 [monthly]

    Completed NA

    Status: RecruitingCompleted

Show 1 earlier version
  1. Jun 2018 — Apr 2019 [monthly]

    Recruiting NA

    First recorded

Jul 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Universidad de Antioquia
Data source: Universidad de Antioquia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations